Angela Calvi
Overview
Explore the profile of Angela Calvi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
128
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Crocco M, Malerba F, Calvi A, Zampatti N, Valitutti F, Pisciotta L, et al.
Dig Liver Dis
. 2025 Jan;
PMID: 39800588
Background: In pediatric patients, celiac disease (CD) may influence the health-related quality of life (HRQoL). Aims: The study aimed to assess HRQoL and further characterise the clinical factors associated with...
2.
Bianchi P, Lenti M, Petrucci C, Gambini G, Aronico N, Varallo M, et al.
JAMA Netw Open
. 2024 Apr;
7(4):e245671.
PMID: 38592719
Importance: The extent and factors associated with risk of diagnostic delay in pediatric celiac disease (CD) are poorly understood. Objectives: To investigate the diagnostic delay of CD in childhood, and...
3.
Crocco M, Malerba F, Calvi A, Zampatti N, Gandullia P, Madeo A, et al.
J Pediatr Gastroenterol Nutr
. 2024 Jan;
78(1):105-112.
PMID: 38291681
Objectives: The aim of the study was to assess long-term health-related quality of life (HRQoL) in children and adolescents with coeliac disease (CD), and their parents. Methods: We re-evaluated prospectively...
4.
Crocco M, Calvi A, Canzoneri F, Malerba F, Zampatti N, Chiaro A, et al.
Nutrients
. 2023 Feb;
15(3).
PMID: 36771266
Celiac disease (CD) has a high prevalence but remains largely underdiagnosed. Although extensive studies have confirmed that children with CD do not have an increased risk of severe COVID-19, public...
5.
Valitutti F, Leonard M, Kenyon V, Montuori M, Piemontese P, Francavilla R, et al.
Am J Gastroenterol
. 2023 Feb;
118(3):574-577.
PMID: 36727859
Introduction: The purpose of this study was to identify possible serum biomarkers predicting celiac disease (CD) onset in children at risk. Methods: A subgroup from an ongoing, international prospective study...
6.
Crocco M, Calvi A, Gandullia P, Malerba F, Mariani A, DI Profio S, et al.
Nutrients
. 2021 Feb;
13(2).
PMID: 33540585
We aimed to assess Health-Related Quality of Life (HRQoL) of Italian children and their parents with coeliac disease (CD) using the Coeliac Disease Dutch Questionnaire (CDDUX). The CDDUX underwent a...
7.
Furnari M, De Alessandri A, Cresta F, Haupt M, Bassi M, Calvi A, et al.
J Gastroenterol
. 2018 Sep;
54(3):261-270.
PMID: 30232597
Background: Scientific literature shows a high prevalence of Small Intestinal Bacterial Overgrowth (SIBO) in patients with Cystic Fibrosis (CF). The role of SIBO in nutritional status and gastrointestinal symptoms in...
8.
Bramuzzo M, Stocco G, Montico M, Arrigo S, Calvi A, Lanteri P, et al.
Inflamm Bowel Dis
. 2017 Aug;
23(10):1810-1816.
PMID: 28817461
Background: Thalidomide is an effective therapy in children with inflammatory bowel disease refractory to standard treatments, but thalidomide-induced peripheral neuropathy (TiPN) limits its long-term use. We aimed to investigate the...
9.
Lazzerini M, Villanacci V, Pellegrin M, Martelossi S, Magazzu G, Pellegrino S, et al.
Clin Gastroenterol Hepatol
. 2017 Mar;
15(9):1382-1389.e1.
PMID: 28286192
Background & Aims: Mucosal healing, determined by endoscopic evaluation, is one of the most important prognostic markers for patients with inflammatory bowel diseases. Findings from histologic evaluation, however, could complement...
10.
Lazzerini M, Martelossi S, Magazzu G, Pellegrino S, Lucanto M, Barabino A, et al.
Inflamm Bowel Dis
. 2015 Jul;
21(8):1739-49.
PMID: 26185909
Background: In a randomized controlled trial, thalidomide has shown to be effective in refractory Crohn's disease in children. This pilot study aimed at evaluating thalidomide in refractory pediatric ulcerative colitis...